Bernal W, Wendon J. Acute liver failure. N Engl J Med. 2013;369:2525–34.
Bernal W, Hyyrylainen A, Gera A, et al. Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol. 2013;59:74–80.
Reuben A, Tillman H, Fontana RJ, et al. Outcomes in adults with acute liver failure between 1998 and 2013: an observational cohort study. Ann Intern Med. 2016;164:724–32.
Squires RH Jr. Acute liver failure in children. Semin Liver Dis. 2008;28:153–66.
Mendizabal M, Marciano S, Videla MG, et al. Changing etiologies and outcomes of acute liver failure: perspectives from 6 transplant centers in Argentina. Liver Transpl. 2014;20:483–9.
Nakao M, Nakayama N, Uchida Y, et al. Nationwide survey for acute liver failure and late-onset hepatic failure in Japan. J Gastroenterol. 2018;53:752-769. https://doi.org/10.1007/s00535-017-1394-2.
Donnelly MC, Davidson JS, Martin K, et al. Acute liver failure in Scotland: changes in aetiology and outcomes over time (the Scottish Look-Back Study). Aliment Pharmacol Ther. 2017;45:833–43.
Shalimar, Kedia S, Gunjan D, et al. Acute liver failure due to hepatitis E virus infection is associated with better survival than other etiologies in Indian patients. Dig Dis Sci. 2017;62:1058–66.
Koch DG, Speiser JL, Durkalski V, et al. The natural history of acute liver injury. Am J Gastroenterol. 2017;112:1389–96.
James LP, Letzig L, Simpson PM, et al. Pharmacokinetics of acetaminophen-protein adducts in adults with acetaminophen overdose and acute liver failure. Drug Metab Dispos. 2009;37:1779–84.
Somasekar S, Lee D, Rule J, et al. Viral surveillance in serum samples from patients with acute liver failure by metagenomic Next-Generation sequencing. Clin Infect Dis. 2017;65:1477–85.
NIH policy on reporting race and ethnicity data: subjects—NIH OER. Racial and Ethnic Categories and Definitions for NIH Diversity Programs and for Other Reporting Purposes, Notice Number: NOT-OD-15-089, released on 8 April 2015. https://grants.nih.gov/grants/guide/notice-files/NOT-OD-01-053.html
Schiødt FV, Ott P, Christensen E, Bondesen S. The value of plasma acetaminophen half-life in antidote-treated acetaminophen overdosage. Clin Pharmacol Ther. 2002;71:221–5.
Khandelwal N, James LP, Sanders C, Larson AM, Lee WM; Acute Liver Failure Study Group. Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure. Hepatology. 2011;53:567–76; https://doi.org/10.1002/hep.24060.
Larson AM, Polson J, Fontana RJ, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005;42:1364–72.
Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–38.
Hennes EM, Zeniya M, Czaja AJ, et al. International Autoimmune Hepatitis Group simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169–76.
Stravitz RT, Lefkowitch JH, Fontana RJ, et al. Autoimmune acute liver failure: proposed clinical and histological criteria. Hepatology. 2011;53:517–26.
Korman JD, Volenberg I, Balko J, et al. Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests. Hepatology. 2008;48:1167–74.
Parekh J, Matei VM, Canas-Coto A, Friedman D, Lee WM, the Acute Liver Failure Study Group. Budd-Chiari syndrome causing acute liver failure: a multicenter case series. Liver Transpl. 2017;23:135–42.
Rockey DC, Seeff LB, Rochon J, et al. Causality assessment in drug induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method. Hepatology. 2010;51:2117–26.
Chalasani N, Fontana RJ, Watkins PB, et al. Drug Induced Liver Injury Network, (DILIN). Causes, clinical features and outcomes from a prospective study, of drug induced liver injury in The United States. Gastroenterology. 2008;135:1924–34.
Ostapowicz G, Fontana RJ, Schiødt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137:947–54.
Schiødt FV, Davern TJ, Shakil AO, et al. Viral hepatitis- related acute liver failure. Am J Gastroenterol. 2003;98:448–53.
Fontana RJ, Engle RE, Scaglione S, et al. The role of hepatitis E virus infection in Adult Americans with acute liver failure. Hepatology. 2016;64:1870–80.
Fong TL, Klontz KC, Canas-Coto A, et al. Hepatotoxicity due to Hydroxycut: a case series. Am J Gastroenterol. 2010;105:1561–6.
O’Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet. 1993;342:273–5.
Roberts DW, Lee WM, Hinson JA, et al. An immunoassay to rapidly measure acetaminophen protein adducts accurately identifies patients with acute liver injury or failure. Clin Gastroenterol Hepatol. 2017;15:555–62.
Lee WM, Hynan LS, Rossaro L, et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology. 2009;137:856–64.
Fix O, Liou I, Karvellas CJ, et al. Acute Liver Failure Study Group. Development and pilot of a checklist for management of acute liver failure in the intensive care unit. PLoS ONE. 2016;11:1–11.
Donaldson BW, Gopinath R, Wanless IR, et al. The role of transjugular liver biopsy in fulminant liver failure: relation to other prognostic indicators. Hepatology. 1993;18:1370–6.